American Well Corporation
NYSE:AMWLMedical - Healthcare Information Services
+$0.24 today
- Market cap
- $171.77M
- Beta
- 1.70
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$5.30
Volume 0.06M
Average 0.07M
AMWL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
American Well CorporationNYSE: AMWL
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$2.43M, compared with -$9.99M a year earlier. Trailing-twelve-month EBITDA was -$53.01M.
Context
- EBITDA amounted to 24.3% of revenue in FY2025, down 45.3 pp from a year earlier.
- EBITDA grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of -$8.68M (+85.7%) for the fiscal year ending Dec 2026, a step up from the +65.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$2.43M+86.0% QoQ
- Last fiscal yearDec 2025
- -$60.57M+65.8% YoY
- LTMMar 2026
- -$53.01M+56.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +75.7% | +41.5% | -34.2 pp |
| 1 year | +65.8% | +85.7% | +19.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (60.57M) USD
- Year-over-year change
- +65.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (60.57M) | +65.8% |
| FY2024 | 2024-12-31 | (176.91M) | +21.1% |
| FY2023 | 2023-12-31 | (224.15M) | +8.8% |
| FY2022 | 2022-12-31 | (245.84M) | -48.0% |
| FY2021 | 2021-12-31 | (166.07M) | — |
EBITDA vs competitors
How AMWL compares with its peers on the latest reported figures
- AMWL's LTM Mar 2026 EBITDA of -$53.01M is the 5th highest of the 9 companies compared; the peer median is -$60.46M.
- Its year-over-year change of +56.9% is the 2nd highest of 9, against a peer median of -9.4%.
- EBITDA amounts to 22.3% of revenue for AMWL, versus a peer median of 708.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | -$3.28M | -77.0% | — | 26.9% | |
| LTM Mar 2026 | -$40.42M | -143.9% | — | 89.7% | |
| LTM Mar 2026 | -$46.12M | +63.6% | — | — | |
| LTM Mar 2026 | -$52.24M | -1.2% | — | 1327.8% | |
| LTM Mar 2026 | -$53.01M | +56.9% | — | 22.3% | |
| LTM Mar 2026 | -$68.69M | -10.6% | — | 36154.2% | |
| LTM Mar 2026 | -$86.7M | +32.0% | — | — | |
| LTM Mar 2026 | -$104.13M | -8.2% | — | — | |
| LTM Mar 2026 | -$106.88M | -21.2% | — | — | |
| Peer median (excluding AMWL) | -$60.46M | -9.4% | — | 708.7% | |
Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 252.79M | 277.19M | 259.05M | 254.36M | 249.33M |
| Cost of Revenue | 148.47M | 160.42M | 164.29M | 155.41M | 116.47M |
| Gross Profit | 104.32M | 116.77M | 94.76M | 98.95M | 132.86M |
| Gross Margin | 41.3% | 42.1% | 36.6% | 38.9% | 53.3% |
| Research & Development | 106.59M | 138.49M | 105.83M | 86.07M | 72.86M |
| Selling, General & Admin | 160.78M | 227.98M | 213.11M | 197.45M | 131.31M |
| Operating Expenses | 283.46M | 392.62M | 786.9M | 316.49M | 238.13M |
| Depreciation & Amortization | 16.09M | 26.17M | 31.51M | 32.98M | 33.96M |
| EBITDA | (166.07M) | (245.84M) | (224.15M) | (176.91M) | (60.57M) |
| EBITDA Margin | -65.7% | -88.7% | -86.5% | -69.6% | -24.3% |
| Operating Income | (179.15M) | (275.85M) | (692.14M) | (217.53M) | (105.27M) |
| Operating Margin | -70.9% | -99.5% | -267.2% | -85.5% | -42.2% |
| Interest Income | 120K | 6.12M | 19.42M | 10.76M | 3.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (3.01M) | 3.85M | 16.83M | 7.65M | 10.74M |
| Income Before Tax | (182.16M) | (272.01M) | (675.31M) | (209.89M) | (94.53M) |
| Pre-Tax Margin | -72.1% | -98.1% | -260.7% | -82.5% | -37.9% |
| Income Tax Expense | (5.38M) | 64K | 3.86M | 2.75M | 434K |
| Net Income | (176.33M) | (270.43M) | (675.16M) | (208.14M) | (95.7M) |
| Net Margin | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% |
| EPS (Basic) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| EPS (Diluted) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| Weighted Avg Shares | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
| Weighted Avg Shares (Diluted) | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
American Well Corporation
NYSE:AMWL
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.